Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-1.92%
1,092.74
-21.40
-1.92%
—1,114.141,119.391,121.191,092.22——
SIXC
Communications
SIXC
Communications
SIXC
-0.04%
613.36
-0.24
-0.04%
—613.60613.60617.80611.65——
SIXE
Energy
SIXE
Energy
SIXE
-1.82%
1,176.79
-21.77
-1.82%
—1,198.561,188.461,188.461,159.56——
SIXI
Industrials
SIXI
Industrials
SIXI
-1.62%
1,755.54
-28.91
-1.62%
—1,784.451,788.951,792.831,749.89——
SIXM
Financials
SIXM
Financials
SIXM
-0.57%
635.15
-3.64
-0.57%
—638.79638.37641.72633.76——
SIXR
Staples
SIXR
Staples
SIXR
-0.29%
848.01
-2.49
-0.29%
—850.50848.90851.07839.52——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0.83%
217.86
-1.83
-0.83%
—219.69219.69219.69216.89——
SIXT
Technology
SIXT
Technology
SIXT
-0.20%
3,417.35
-6.84
-0.20%
—3,424.193,429.183,463.333,398.08——
SIXU
Utilities
SIXU
Utilities
SIXU
-1.34%
913.36
-12.40
-1.34%
—925.76922.77923.99911.22——
SIXV
Health care
SIXV
Health care
SIXV
-0.48%
1,462.38
-7.02
-0.48%
—1,469.401,468.961,473.181,457.86——
SIXY
Discretionary
SIXY
Discretionary
SIXY
-0.06%
2,423.14
-1.48
-0.06%
—2,424.622,438.232,446.632,412.48——
Q1 2026 earnings • released • EPS miss -34.67% • Revenue miss -1.01%
See results
MYGN:NASDAQ
Myriad Genetics Inc
$4.09
-0.49%
(-0.020) 1D
$4.09
0.00% (0.00)
After hours
Closed: May 7, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for MYGN...
Open
$4.13
High
$4.22
Low
$4.02
Mkt. cap
386.27M
Avg. vol.
1.32M
Volume
0.00
52-wk high
$8.59
52-wk low
$3.75
EPS
-$3.95
Beta
1.81
Shares outstanding
93.51M
No. of employees
3K
News stories
From sources across the web
Profile
Myriad Genetics, Inc. is an American genetic testing and precision medicine company based in Salt Lake City, Utah, United States. Myriad employs a number of proprietary technologies that permit doctors and patients to understand the genetic basis of human disease and the role that genes play in the onset, progression and treatment of disease. This information is used to guide the development of new products that assess an individual's risk for developing disease later in life, identify a patient's likelihood of responding to a particular drug therapy, assess a patient's risk of disease progression and disease recurrence, and measure disease activity. Wikipedia
About Myriad Genetics Inc
CEOPaul J. Diaz | Paul J. Diaz
Employees2.7K
Founded1991
HeadquartersSalt Lake City, Utah, United States
SectorBiotechnology
Websitemyriad.com
Last report
May 5, 2026
Fiscal Period
Q1 2026
EPS / Est. (USD)
-$0.09 / -$0.07
-34.67%miss
Revenue / Est. (USD)
200.40M / 202.44M
-1.01%miss
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
213.10M
205.70M
209.80M
200.40M
Cost of goods sold
61.30M
61.90M
63.00M
62.80M
Cost of revenue
61.30M
61.90M
63.00M
62.80M
Research and development expenses
25.60M
28.20M
25.50M
27.10M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
138.70M
138.90M
124.30M
135.80M
Operating expense
164.30M
167.10M
149.80M
162.90M
Total operating expenses
225.60M
229.00M
212.80M
225.70M
Operating income
-12.50M
-23.30M
-3.00M
-25.30M
Other non operating income
-100.00K
400.00K
400.00K
-
EBT including unusual items
-330.60M
-26.20M
-8.90M
-34.10M
EBT excluding unusual items
-13.90M
-26.20M
-6.20M
-28.70M
Income tax expense
-100.00K
1.20M
-1.00M
-
Effective tax rate
0.03%
-4.58%
11.24%
-
Other operating expenses
-
-
-
-
Net income
-330.50M
-27.40M
-7.90M
-34.10M
Net profit margin
-155.09%
-13.32%
-3.77%
-17.02%
Earnings per share
0.05
-
0.04
-0.09
Interest and investment income
200.00K
500.00K
800.00K
700.00K
Interest expense
-1.50M
-3.80M
-4.40M
-4.10M
Net interest expenses
-1.30M
-3.30M
-3.60M
-3.40M
Depreciation and amortization charges
-
-
-
-
EBITDA
1.60M
-10.70M
9.60M
-11.88M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer